Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Pfizer spinout Cerevel hires Coles as CEO
Fierce Biotech
Mon, 09/9/19 - 10:34 am
Tags:
Tony Coles, Cerevel Therapeutics, Pfizer, Pharma CEOs, Neuroscience
With FDA’s Eye on JAK Drugs, Concert Moves One Ahead For Hair Loss
Xconomy
Tue, 09/3/19 - 10:28 am
Tags:
Concert Pharmaceuticals, Pfizer, JAK inhibitors, CTP-543, alopecia areata
SpringWorks Therapeutics Updates Filing for $143+ Million IPO
CP Wire
Tue, 09/3/19 - 10:26 am
Tags:
SpringWorks Therapeutics, IPOs, nirogacestat, mirdametinib, Pfizer
Tue, 09/3/19 - 09:50 am
Tags:
SpringWorks Therapeutics, IPOs, nirogacestat, mirdametinib, Pfizer
ESC: New Pfizer, BMS real-world data could boost Eliquis in Europe
Fierce Pharma
Mon, 09/2/19 - 12:17 pm
Tags:
Pfizer, Bristol-Myers Squibb, Eliquis, Warfarin, bloodthinners, Europe, ESC, European Society of Cardiology
Three strategies for managing loss of exclusivity successfully
Pharmaforum
Thu, 08/29/19 - 11:49 pm
Tags:
market exclusivity, patents, Humalog, Viagra, Eli Lilly, Pfizer
Towards patient centricity: Pfizer
Pharmaforum
Thu, 08/29/19 - 10:10 am
Tags:
Pfizer, patients, patient centricity
FTC Issues Civil Investigative Demand to Johnson & Johnson Regarding Remicade
Big Molecule Watch
Sun, 08/25/19 - 05:02 pm
Tags:
Remicade, JNJ, Pfizer, antitrust, Walgreens, Kroger
Pfizer, Astellas rocket toward broader Xtandi use with FDA 'priority' tag
Fierce Pharma
Thu, 08/22/19 - 11:56 am
Tags:
Pfizer, Astellas, Xtandi, prostate cancer, FDA, priority review
Pfizer injects $500M more into gene therapy manufacturing
Biopharma Dive
Wed, 08/21/19 - 11:44 pm
Tags:
Pfizer, gene therapy, drug manufacturing, North Carolina
Lyrica looking grim: Pfizer blockbuster's market share crumbles under generic attack
Fierce Pharma
Mon, 08/19/19 - 11:46 pm
Tags:
Pfizer, patents, Lyrica, generics
Is Pfizer's established drugs' decline in China the ‘canary in the coalmine?’
Fierce Pharma
Mon, 08/19/19 - 11:55 am
Tags:
Pfizer, Upjohn, China
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
Xconomy
Sat, 08/17/19 - 01:28 pm
Tags:
IPOs, SpringWorks Therapeutics, Pfizer, Satsuma Pharmaceuticals
5 Biggest New Drugs Approved in 2019 So Far
Motley Fool
Tue, 08/13/19 - 11:43 am
Tags:
drug approvals, FDA, AbbVie, JNJ, Novartis, Pfizer, Skyrizi, psoriasis, Vyndaqel, Zolgensma, SMA, Mayzent, multiple sclerosis, Balversa, metastatic bladder cancer
Hospitals rationing immune disorder drug
Beckers Hospital Review
Fri, 08/9/19 - 07:37 pm
Tags:
Human Immune Globulin Infusion, drug shortages, Pfizer, Takeda
GlycoMimetics shares crash after Pfizer team dismisses their lead drug as a PhIII failure
Endpoints
Mon, 08/5/19 - 12:03 am
Tags:
Pfizer, GlycoMimetics, sickle cell disease, Rivipansel
These 5 Prescription Drugs Will Generate a Jaw-Dropping $62.3 Billion in 2024
Yahoo/Motley Fool
Sun, 08/4/19 - 01:02 pm
Tags:
Merck, Keytruda, AbbVie, Humira, Pfizer, Bristol-Myers Squibb, Eliquis, JNJ, Imbruvica
Mylan-Upjohn Merger Leaves Analysts Skeptical
Xtalks
Sat, 08/3/19 - 02:38 pm
Tags:
analysts, M&A, Mylan, Pfizer, Upjohn
After Mylan Gets Acquired, Could Teva Be Next?
Yahoo/Guru Focus
Sat, 08/3/19 - 12:57 pm
Tags:
Pfizer, Upjohn, Mylan, Teva Pharmaceutical, M&A
Pfizer may send EpiPen manufacturing to generics spinoff
Biopharma Dive
Fri, 08/2/19 - 12:18 am
Tags:
Pfizer, Mylan, M&A, Meridian Medical Technologies, EpiPens, drug shortages

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.